Review Article
Immunohistochemical Biomarkers in Gastric Cancer Research and Management
Table 2
HER2 testing by immunohistochemistry in gastric cancer.
| IHC parameters for HER2 testing protocol | IHC score | Classification |
| Intensity of reactivity | | | Absent |
0 | Negative | Faint |
1+ | Negative | Weak to moderate |
2+ | Equivocal* | Moderate to strong |
3+ | Positive |
| Degree of membrane reactivity | | | Complete |
2+ | Equivocal* |
3+ | Positive | Incomplete |
0 | Negative |
1+ | Negative |
| Percentage of immunoreactive cells (membrane reactivity) | | | ≥10% |
1+ | Negative |
2+ | Equivocal* |
3+ | Positive | <10% |
0 | Negative |
|
|
*
Samples scored IHC 2+ should be retested with fluorescence in situ hybridization (FISH) or chromogenic in situ hybridization (CISH).
|